AC-4-130

N/A

Report date: 2024/11/05 16:40:41
NME

Base Information

Drug NameAC-4-130
Drug Alias NameAC-4-130
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSTAT5 transcription factor inhibitors
TargetsSTAT5 transcription factor
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLudwig Boltzmann Institute for Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesLudwig Boltzmann Institute for Cancer Research
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A